CGB 0.00% 2.1¢ cann global limited

Ann: Research results lead to broader auto-immune research, page-6

  1. 4,882 Posts.
    lightbulb Created with Sketch. 259
    Announcement is positive but no details on expected costs of the next round of trials and how this is being funded?
 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.